During the past decade, Xiangya Hospital, Central South University conducted 361 clinical trials. In the 10-year time frame, 361 clinical trials started and 35 clinical trials were completed, i.e. on average, 9.7% percent of trials that started reached the finish line to date. In the past 5 years, 223 clinical trials started and 25 clinical trials were completed. i.e. 11.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Xiangya Hospital, Central South University" #1 sponsor was "Xiangya Hospital of Central South University" with 62 trials, followed by "Eli Lilly and Company" with 16 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 13 trials sponsored, "Nanfang Hospital of Southern Medical University" with 13 trials sponsored and "Central South University" with 13 trials sponsored. Other sponsors include 303 different institutions and companies that sponsored additional 170 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Xiangya Hospital, Central South University" #1 collaborator was "Xiangya Hospital of Central South University" with 27 trials as a collaborator, "Henan Provincial People's Hospital" with 10 trials as a collaborator, "Peking University First Hospital" with 8 trials as a collaborator, "Qilu Hospital of Shandong University" with 7 trials as a collaborator and "West China Hospital" with 7 trials as a collaborator. Other collaborators include 637 different institutions and companies that were collaborators in the rest 415 trials.

According to Clinical.Site data, the most researched conditions in "Xiangya Hospital, Central South University" are "Chronic Hepatitis B" (13 trials), "Hemophilia A" (9 trials), "Hepatitis B, Chronic" (9 trials), "Pulmonary Arterial Hypertension" (8 trials) and "Nasopharyngeal Carcinoma" (7 trials). Many other conditions were trialed in "Xiangya Hospital, Central South University" in a lesser frequency.

Most popular intervention types in "Xiangya Hospital, Central South University" are "Drug" (276 trials), "Device" (41 trials), "Other" (35 trials), "Biological" (32 trials) and "Procedure" (17 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (63 trials), "placebo" (10 trials), "Pembrolizumab" (9 trials), "Cisplatin" (8 trials) and "Lenvatinib" (6 trials). Other intervention names were less common.

The vast majority of trials in "Xiangya Hospital, Central South University" are 398 trials for "All" genders, 15 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 209 active trials in "Xiangya Hospital, Central South University". 15 are not yet recruiting, 131 are recruiting, 58 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 106 completed trials in Xiangya Hospital, Central South University, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Xiangya Hospital, Central South University, 43 "Phase 1" clinical trials were conducted, 85 "Phase 2" clinical trials and 138 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 38 trials, and there were also 51 trials that are defined as “Not Applicable".

Xiangya Hospital, Central South University has several departments that took part in Clinical trials: "Department of PET Center,Xiangya Hospital,Central South University" - 2 trials